sglt2 inhibitors & cardiovascular outcome
Published Streamed 1 year ago • 525 plays • Length 1:23:07Download video MP4
Download video MP3
Similar videos
-
7:14
sglt2 inhibitors and cardiovascular outcomes in type 2 diabetes: vertis cv trial
-
8:15
sglt2 inhibitors and heart failure
-
10:37
cardiovascular outcomes in new users of sglt-2 inhibitors
-
13:49
using sglt2-inhibitors to treat cardiac patients with diabetes
-
2:27
cardiovascular benefit with sglt2 inhibition
-
1:06:15
a tale of salt and sugar: sglt2 inhibitors in cardiovascular disease
-
52:01
cardiovascular risk reduction with sglt2 inhibitors and glpl agonists
-
2:59
assimilating the evidence in t2dm: cardiovascular and renal outcomes with sglt2 inhibitors
-
8:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - summary presentation
-
22:15
sglt-2 inhibitors for type 2 diabetes - amel arnaout, md
-
3:40
using sglt2 inhibitors to achieve cardiovascular benefits
-
50:30
protocols for safe use of sglt2i and glp1ra in the hospital setting
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond
-
12:49
esc tv conversations - sglt2 inhibitors – wonder drugs in heart failure and beyond?
-
23:00
professor niko marx - the therapeutic importance of sglt2 inhibition – heart failure the new target!
-
38:55
professor milton packer - 'heart failure – are there limits to anti-diabetic therapy with sglt2'
-
1:02:19
cardiovascular, renal and metabolic benefits of sglt2i for type 2 diabetes and heart failure
-
27:44
are there alternative mechanisms to explain sglt2i beneficial cveffects in some patients?